Cargando…
In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer
BACKGROUND: Endometrial cancer is the most common cancer of the female reproductive tract. Based on our previous studies we speculated that miR-92a exhibited pro-oncogenic properties in endometrial cancer, and therefore its inhibition could be used as a therapeutic measure in this disease. Therefore...
Autores principales: | Torres, Anna, Kozak, Joanna, Korolczuk, Agnieszka, Wdowiak, Paulina, Domańska-Glonek, Ewa, Maciejewski, Ryszard, Torres, Kamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080781/ https://www.ncbi.nlm.nih.gov/pubmed/27782822 http://dx.doi.org/10.1186/s12885-016-2867-z |
Ejemplares similares
-
Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer
por: Torres, Anna, et al.
Publicado: (2016) -
Locked nucleic acid-inhibitor of miR-205 decreases endometrial cancer cells proliferation in vitro and in vivo
por: Torres, Anna, et al.
Publicado: (2016) -
A guide for endometrial cancer cell lines functional assays using the measurements of electronic impedance
por: Kozak, Joanna, et al.
Publicado: (2017) -
Interactions between microRNA-200 family and Sestrin proteins in endometrial cancer cell lines and their significance to anoikis
por: Kozak, Joanna, et al.
Publicado: (2019) -
NMR solution structures of LNA (locked nucleic acid) modified quadruplexes
por: Nielsen, Jakob T., et al.
Publicado: (2006)